BML Capital Management, LLC
CIK: 0001616824SEC EDGAR →
Portfolio Value
$115.7M
Holdings
16
As of
Q4 2025
New Positions
5
Closed Positions
6
Portfolio Value History
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | ACLARIS THERAPEUTICS INC | 14,250,000 | $42.9M | 37.08% |
| 2 | ATEA PHARMACEUTICALS INC | 7,490,000 | $26.7M | 23.11% |
| 3 | ORAMED PHARMACEUTICALS INC | 3,167,231 | $9.0M | 7.80% |
| 4 | INSTIL BIO INC | 645,600 | $7.1M | 6.14% |
| 5 | PMV PHARMACEUTICALS INC | 5,292,000 | $6.6M | 5.72% |
| 6 | CARMAX INC | 155,000 | $6.0M | 5.18% |
| 7 | KEZAR LIFE SCIENCES INC | 720,787 | $4.5M | 3.92% |
| 8 | TARGET CORP | 37,500 | $3.7M | 3.17% |
| 9 | CVNAPut CARVANA CO | 150 | $2.0M | 1.74% |
| 10 | OUTSET MED INC | 543,180 | $2.0M | 1.74% |
Quarterly Changes
New Positions (5)
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 11 | $103.3M | 89.3% |
| Consumer Cyclical | 3 | $8.2M | 7.1% |
| Unknown | 1 | $3.7M | 3.2% |
| Consumer Defensive | 1 | $492K | 0.4% |